First Look Analysts Research Calls for Thursday, March 23
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Accolade (ACCD) upgraded to Buy from Neutral at Guggenheim; tgt $16 > Americold Realty Trust (COLD) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $32 >…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Accolade (ACCD) upgraded to Buy from Neutral at Guggenheim; tgt $16
> Americold Realty Trust (COLD) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $32
> ArcelorMittal (MT) upgraded to Buy from Neutral at BofA Securities
> BellRing Brands (BRBR) upgraded to Buy from Hold at Truist; tgt raised to $40
> Inozyme Pharma (INZY) upgraded to Buy from Hold at Jefferies; tgt raised to $6
> Marathon Oil (MRO) upgraded to Buy from Neutral at Citigroup; tgt $27
> ORIC Pharmaceuticals (ORIC) upgraded to Buy from Neutral at H.C. Wainwright; tgt $16
> Pioneer Natural Resources (PXD) upgraded to Buy from Neutral at Citigroup; tgt raised to $210
> Regency Centers (REG) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $70
Downgrades:
> Amwell (AMWL) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $2.50
> Boston Properties (BXP) downgraded to Equal Weight from Overweight at Barclays; tgt $57
> Chewy (CHWY) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $35
> Coinbase Global (COIN) downgraded to Perform from Outperform at Oppenheimer
> M&T Bank (MTB) downgraded to Peer Perform from Outperform at Wolfe Research
> nCino (NCNO) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
> Ovintiv (OVV) downgraded to Neutral from Buy at Citigroup; tgt lowered to $38
> Samsara (IOT) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $19
> SL Green Realty (SLG) downgraded to Underweight from Equal Weight at Barclays; tgt $22
Others:
> AMC Entertainment (AMC) resumed with a Sell at Citigroup; tgt $1.60
> Disc Medicine (IRON) initiated with an Outperform at BMO Capital Markets; tgt $40
> Dynatrace (DT) initiated with a Buy at Stifel; tgt $45
> HashiCorp (HCP) initiated with a Buy at BTIG Research; tgt $37
> IDEAYA Biosciences (IDYA) initiated with a Buy at Berenberg; tgt $26
> Intuitive Surgical (ISRG) initiated with an Outperform at William Blair
> Mobileye Global (MBLY) initiated with a Hold at WestPark Capital
> NVIDIA (NVDA) initiated with a Hold at WestPark Capital
> Qualcomm (QCOM) initiated with a Hold at WestPark Capital
> Roper (ROP) initiated with a Neutral at Mizuho; tgt $475
> Select Energy Services (WTTR) initiated with a Strong Buy at Raymond James; tgt $12
> Sociedad Quimica y Minera (SQM) initiated with an Outperform at Bradesco BBI
> Talos Energy (TALO) initiated with an Overweight at KeyBanc Capital Markets; tgt $18
> Western Alliance Bancorp (WAL) initiated with an Outperform at Hovde Group
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.